EMN

Eastman Chemical Company - 10-Q Summary (Q3 2006)

Business Context and Reporting Period

This filing is a Quarterly Report on Form 10-Q for Eastman Chemical Company for the period ended September 30, 2006. Eastman is a large accelerated filer incorporated in Delaware. The company operates five reportable segments: CASPI, Fibers, Performance Chemicals and Intermediates (PCI), Performance Polymers, and Specialty Plastics (SP). The reporting period reflects a strategic realignment of the organizational structure in Q1 2006 to eliminate intersegment sales revenue and operating earnings.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Sales increased 8% in Q3 and 7% for the first nine months of 2006 compared to 2005. This growth was driven primarily by higher selling prices (9% impact in Q3) to offset rising raw material and energy costs, rather than volume growth.
• Margin Compression: Gross profit margins declined significantly (from 19% to 16% in Q3) due to increased costs for paraxylene and propane that were only partially passed through to customers.
• Profit Decline: Operating earnings fell 20% in Q3 and 18% for the nine-month period. Net earnings dropped 23% in Q3 and 36% for the nine-month period. The 2005 prior-year results included a one-time $171 million gain from the sale of the Genencor equity investment and $46 million in early debt extinguishment costs, which are not present in 2006.
• Restructuring Charges: The company recorded $13 million in asset impairments and restructuring charges in Q3 2006 (vs. $4 million in Q3 2005), primarily related to the divestiture of the Batesville, Arkansas facility.
• Cash Flow: Operating cash flow decreased by $144 million in the first nine months of 2006 compared to the prior year, attributed to lower net earnings and increased working capital requirements.

Guidance, Outlook, and Risks

• Divestitures: The company has entered definitive agreements to sell the Batesville, Arkansas facility (PCI segment) and the polyethylene/Epolene polymer businesses (Performance Polymers and CASPI segments) for a total of $330 million. Completion is expected in Q4 2006.
• Future Charges: Management announced a decision to cease production of CHDM modified polymers in Spain, expecting approximately $25 million in impairment and restructuring charges in Q4 2006.
• 2006 Outlook:
  • Capital expenditures expected to be approximately $400 million.
  • Effective tax rate expected to be approximately 34%.
  • R&D expenses expected to be approximately 3% of revenue.
  • Net interest expense expected to decrease compared to 2005.
  • Q4 2006 EPS (excluding gains/charges) expected to be at or above Q4 2005 levels.
• Risks: Key risks include volatility in raw material and energy costs, foreign currency exchange rate fluctuations, and the potential for further restructuring or divestitures. The company is also subject to environmental liabilities and ongoing litigation (including asbestos and sorbates cases), though management does not believe these will have a material adverse effect.

Investor Verification Checklist

• Divestiture Timing: Verify the closing dates and regulatory approvals for the $330 million asset sales (Batesville and Polyethylene/Epolene) expected in Q4 2006.
• Q4 Restructuring Impact: Confirm the magnitude and timing of the anticipated $25 million charge related to the Spain facility closure.
• Raw Material Hedging: Review the effectiveness of hedging strategies against continued volatility in paraxylene and propane prices, which are compressing margins.
• Working Capital Trends: Monitor the increase in working capital (receivables and inventories) that contributed to the decline in operating cash flow.
• Pension Funding: Note that the company contributed $75 million to U.S. defined benefit plans in the first nine months and expects no further contributions in 2006, but is evaluating the impact of new accounting standards (SFAS 158) on equity.